Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Der Urologe. Ausg. A|May 1, 1989
[Treatment of staghorn calculi. Strategies and results of the combined use of new technics]F Eisenberger, J Rassweiler, B Kallert, et al.
Aktuelle Urologie|June 3, 2010
[Quality of life after radical cystectomy - an overview and analysis of a contemporary series]T Severin, P Bub, D Jocham, et al.
Fortschritte Der Medizin|August 10, 1989
[Extracorporeal shockwave lithotripsy. Current status in treatment of kidney calculus disease]J Rassweiler, F Eisenberger, P Bub, et al.
The Journal of Lithotripsy & Stone Disease|June 8, 1991
Urologic experience with the Dornier multipurpose lithotripter MPL 9000A Schmidt, J Seibold, P Bub, et al.
European Urology|January 1, 1992
Tissue polypeptide antigen for monitoring of advanced bladder cancer after MVEC chemotherapyA Schmidt, P Bub, U Rüther, et al.
The Journal of Urology|January 1, 1987
Prone flexible cystoscopy: an adjunct to percutaneous stone removalR V Clayman, P Bub, E Haaff, et al.
European Urology|January 1, 1989
Technical considerations using a pulsed neodym-YAG laser for endoscopic shock wave lithotripsyJ Rassweiler, U Irion, R Strauss, et al.
Der Urologe. Ausg. A|January 1, 1989
[Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity]J Rassweiler, U Rüther, K Bäuerle, et al.
European Urology|January 1, 1989
Wolf Piezolith 2200 versus the modified Dornier HM3. Efficacy and range of indicationsJ Rassweiler, R Gumpinger, P Bub, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Pageof 2